These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1871435)

  • 21. Eosinophil activation in allergic disease.
    Venge P; Håkansson L; Peterson CG
    Int Arch Allergy Appl Immunol; 1987; 82(3-4):333-7. PubMed ID: 3553024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal.
    Lönnkvist K; Hellman C; Lundahl J; Halldén G; Hedlin G
    J Allergy Clin Immunol; 2001 May; 107(5):812-7. PubMed ID: 11344347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eosinophil degranulation. An immunologic determinant in the pathogenesis of the Mazzotti reaction in human onchocerciasis.
    Ackerman SJ; Kephart GM; Francis H; Awadzi K; Gleich GJ; Ottesen EA
    J Immunol; 1990 May; 144(10):3961-9. PubMed ID: 2332637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hypereosinophilias of the blood. I. Eosinophilic granulocytes].
    Lovisetto P; Manachino D; Biarese V; Marchi L; Andrione P
    Minerva Med; 1985 May; 76(21):975-83. PubMed ID: 3923403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutrophil-specific granule deficiency includes eosinophils.
    Rosenberg HF; Gallin JI
    Blood; 1993 Jul; 82(1):268-73. PubMed ID: 8324226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effects of lodoxamide on eosinophil activation.
    Capron M; Loiseau S; Papin JP; Robertson S; Capron A
    Int Arch Allergy Immunol; 1998 Jun; 116(2):140-6. PubMed ID: 9652307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet-activating factor induces eosinophil peroxidase release from purified human eosinophils.
    Kroegel C; Yukawa T; Dent G; Chanez P; Chung KF; Barnes PJ
    Immunology; 1988 Jul; 64(3):559-61. PubMed ID: 3410498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signal transduction mechanisms in human eosinophils.
    Shute J
    Clin Exp Allergy; 1993 Sep; 23(9):713-7. PubMed ID: 10779300
    [No Abstract]   [Full Text] [Related]  

  • 29. Possible release of eosinophil granule proteins in response to signaling from intercellular adhesion molecule-1 and its ligands.
    Chihara J; Yamamoto T; Kurachi D; Kakazu T; Higashimoto I; Nakajima S
    Int Arch Allergy Immunol; 1995; 108 Suppl 1():52-4. PubMed ID: 7549525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The molecular biology of eosinophil granule proteins.
    Hamann KJ; Barker RL; Ten RM; Gleich GJ
    Int Arch Allergy Appl Immunol; 1991; 94(1-4):202-9. PubMed ID: 1657792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of the activation of hageman factor (factor XII) by eosinophils and eosinophilic constituents.
    Ratnoff OD; Gleich GJ; Shurin SB; Kazura J; Everson B; Embury P
    Am J Hematol; 1993 Jan; 42(1):138-45. PubMed ID: 8416290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eosinophils and bronchial inflammation.
    Gleich GJ; Loegering DA; Adolphson CR
    Chest; 1985 Jan; 87(1 Suppl):10S-13S. PubMed ID: 2981057
    [No Abstract]   [Full Text] [Related]  

  • 33. Increased microvascular permeability induced by eosinophil proteins.
    Minnicozzi M; Gleich GJ; Durán WN; Egan RW
    Int Arch Allergy Immunol; 1995; 107(1-3):348. PubMed ID: 7613168
    [No Abstract]   [Full Text] [Related]  

  • 34. Experimental eosinophilia and inflammation--the effect of various inflammatory mediators and chemoattractants.
    Fechter M; Egger D; Auer H; Popper H
    Exp Pathol; 1986; 29(3):153-8. PubMed ID: 3013671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How similar are in vitro differentiated, cord blood derived eosinophils to peripheral blood eosinophils? A comparison of their peroxidase and eosinophil-derived neurotoxin contents and of their responses to various activators.
    Bach MK; Brashler JR; Sanders ME; Furitsu T; Ishizaka T
    Int Arch Allergy Appl Immunol; 1990; 93(4):323-9. PubMed ID: 1966130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of human eosinophils by platelet-derived growth factor.
    Bach MK; Brashler JR; Stout BK; Johnson HG; Sanders ME; Lin AH; Gorman RR; Bienkowski MJ; Ishizaka T
    Int Arch Allergy Immunol; 1992; 97(2):121-9. PubMed ID: 1316315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epithelial injury by human eosinophils.
    Venge P; Dahl R; Fredens K; Peterson CG
    Am Rev Respir Dis; 1988 Dec; 138(6 Pt 2):S54-7. PubMed ID: 3202523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TNF alpha-induced activation of eosinophil oxidative metabolism and morphology--comparison with IL-5.
    Zeck-Kapp G; Czech W; Kapp A
    Exp Dermatol; 1994 Aug; 3(4):176-88. PubMed ID: 8000707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased eosinophil granule proteins in gut lavage fluid from patients with inflammatory bowel disease.
    Levy AM; Gleich GJ; Sandborn WJ; Tremaine WJ; Steiner BL; Phillips SF
    Mayo Clin Proc; 1997 Feb; 72(2):117-23. PubMed ID: 9033543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eosinophils express a functional receptor for interferon alpha: inhibitory role of interferon alpha on the release of mediators.
    Aldebert D; Lamkhioued B; Desaint C; Gounni AS; Goldman M; Capron A; Prin L; Capron M
    Blood; 1996 Mar; 87(6):2354-60. PubMed ID: 8630398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.